Nomura Holdings
SGMO

Nomura Holdings’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Nomura Holdings’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-25,000
Closed -$220K – 1313
2019
Q3 		$220K Buy
+25,000
New +$280K ﹤0.01% 1074
2015
Q2 		– Sell
-12,998
Closed -$206K – 2002
2015
Q1 		$206K Buy
+12,998
New +$201K ﹤0.01% 1501
2014
Q4 		– Sell
-41,460
Closed -$447K – 2654
2014
Q3 		$447K Buy
41,460
+5,547
+15% +$72.5K ﹤0.01% 1902
2014
Q2 		$553K Buy
35,913
+19,690
+121% +$283K ﹤0.01% 1726
2014
Q1 		$295K Buy
+16,223
New +$313K ﹤0.01% 2094
2013
Q3 		– Sell
-36,315
Closed -$285K – 2575
2013
Q2 		$285K Buy
+36,315
New +$317K ﹤0.01% 1633

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nomura Holdings's SGMO Position: Q4 2019 in Review

Nomura Holdings sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2019, closing a stake of 25,000 shares — an estimated $220K sold.

Nomura Holdings first reported a position in SGMO in Q2 2013 and held it in 6 quarters. The position peaked at $553K in Q2 2014. 193 funds tracked by Wall St. Rank hold SGMO as of Q4 2019.

  • Nomura Holdings reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2019 after selling out during the quarter.
  • Nomura Holdings sold 25,000 SANGAMO THERAPEUTICS INC shares in Q4 2019, an estimated $220K.
  • Nomura Holdings first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and held it in 6 quarters.
  • Nomura Holdings's SANGAMO THERAPEUTICS INC position peaked at $553K in Q2 2014.
  • 193 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2019.

Based on Nomura Holdings's 13F filing for Q4 2019, filed 14 Feb 2020.